News
Clene will soon meet with the Food and Drug Administration to discuss analyses that could support an application for ...
Columnist Kristin Neva, inspired by a Bon Iver song, investigates old journals as she thinks about the rhythm of her life.
Columnist Dagmar Munn considers when she decided to share the news that she had ALS — and it wasn't when she felt "ready" to ...
Neurosense Therapeutics said it's producing its ALS therapy PrimeC at a commercial scale as it prepares for potential ...
The ALS therapy ATLX-1282 was developed with AIchemab's platform, which uses AI to identify therapeutic targets for difficult ...
Implanting a sensor in the brain helped detect intended speech and allowed control of a computer for a man with ALS in a ...
The nationwide event will cost $20, with all funds benefiting Augie's Quest, which was founded to fund research and raise ALS ...
Note: This story was updated May 13, 2025, to correct information about the company’s clinical trials. Spinogenix has received clearance from the U.S. Food and Drug Administration (FDA) to launch an ...
My husband, Todd, and I work New York Times puzzles while we eat breakfast. Because Todd is paralyzed due to ALS, I feed him. We start with the Spelling Bee puzzle, which offers seven letters for you ...
Implanting a sensor in a region of the brain that helps to control speech was shown in a U.S. study to not only decode the intended speech of a man with amyotrophic lateral sclerosis (ALS), but also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results